Navigation Links
Perrigo Reports Record Quarterly Revenue and Earnings and Raises Full Year Adjusted EPS Guidance
Date:5/3/2011

generic of Aldara® and the generic version of Xyzal®, as well as $6 million of increased sales volume in the Company's existing products. Reported operating income was $31 million, an increase of approximately $15 million from last year. The increase was driven largely by new product sales and increased operating expense leverage. Reported operating margin increased 430 basis points from last year to 36.9%.  

For the first nine months of fiscal 2011, net sales for the Rx Pharmaceuticals segment increased 62% from fiscal 2010 to $251 million. Net sales increased due primarily to $72 million in new product sales and an increase of $16 million in sales of existing products.  

On February 22, 2011, the Company announced that it had filed an Abbreviated New Drug Application for calcipotriene 0.005% and betamethasone dipropionate 0.064% ointment, a generic form of Taclonex® Ointment.  

API

The API segment reported third quarter net sales of $41 million compared with $33 million a year ago, an increase of 26%. The increase was due primarily to additional sales of existing products of $8 million and new product sales of $5 million led by European sales of temozolomide. The increase was partially offset by an approximately $4 million decrease in revenues related to the sale of dossier agreements. Reported operating income increased $12 million due to higher margin new product sales, decreased operating expenses and improved financial operating leverage. Reported operating margin increased 2920 basis points to 27.5%, and adjusted operating margin increased 820 basis points to 28.7%.  

For the first nine months of fiscal 2011, net sales increased 18% to approximately $119 million, compared to $101 million in fiscal 2010. Reported operating margin increased 1830 basis points to 26.6% from last year's 8.3%.  

Other

Continuing operations for the Other category, consisting of the Israel Ph
'/>"/>

SOURCE Perrigo Company
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18

Related medicine technology :

1. Perrigo Announces FDA Final Approval for Minoxidil Foam - Generic Equivalent to Mens Rogaine® Foam
2. Perrigo Company Announces Quarterly Dividend
3. Perrigos PBM Infant Formula Unit Wins Appellate Judgment Versus Mead Johnson
4. Perrigo Partner Teva Receives Final OTC Approval for Sales and Distribution of Fexofenadine HCl 60 mg and 180 mg Tablets
5. Perrigo Announces Conclusion of the FDA Re-Inspection
6. Perrigo Company to Present at the Barclays Capital 2011 Global Health Care Conference
7. Perrigo Announces Arrival of the FDA for Reinspection Related to the Allegan Facility Warning Letter
8. Perrigo Company to Present at the Citi 2011 Global Health Care Conference
9. Perrigo Confirms Filing for Generic Version of Taclonex® Ointment and Announcement of Lawsuit by Leo Pharma
10. Perrigo Enters Into Exclusive Sales and Distribution Agreement With AgaMatrix for Store Brand Blood Glucose Monitoring Products
11. Perrigo Announces Settlement of Rogaine® Foam Patent Litigation
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/2/2015)... 2, 2015  Maquet Medical Systems ... signed an exclusive distribution agreement with Flight Medical ... the Flight 60 mechanical ventilator. The Flight 60 ... and affordable mobility. Starting in the first quarter ... in the United States ...
(Date:3/2/2015)... , March 2, 2015 Valencia Technologies ... th patient with its radically small device for ... 2015. Valencia,s early results in this randomized, double-blinded, controlled trial ... degree of confidence that it will succeed in a ... its early clinical results, Valencia ...
(Date:3/2/2015)... BOULDER, Colo. , March 2, 2015 /PRNewswire/ ... regarding close of their transactions, Array BioPharma Inc. ... the binimetinib and encorafenib definitive agreements with Novartis.  ... will receive an upfront payment of $85 million ... of Array, noted, "With the close of the ...
Breaking Medicine Technology:Maquet Medical Systems USA to Exclusively Distribute Flight Medical's Flight 60 Respiratory Ventilators 2Maquet Medical Systems USA to Exclusively Distribute Flight Medical's Flight 60 Respiratory Ventilators 3Valencia Technologies Implants its 48th Patient, Continues Equity Crowdfunding 2Array Announces Completion Of Binimetinib And Encorafenib Transactions 2Array Announces Completion Of Binimetinib And Encorafenib Transactions 3Array Announces Completion Of Binimetinib And Encorafenib Transactions 4Array Announces Completion Of Binimetinib And Encorafenib Transactions 5
... 5, 2011 /PRNewswire-Asia/ -- Sinovac Biotech Ltd. (Nasdaq: ... in China, announced today the resignation of Jacob Chik Keung ... has initiated an executive search for a new Chief Financial ... with the Company until August 16, 2011.  Ms. Nan Wang, ...
... 2011 ACCESS PHARMACEUTICALS, INC. (OTCBB: ACCP), ... platforms to develop treatments in areas of oncology, cancer ... full service global public relations firm, to support its ... a media communications outreach program primarily aimed at introducing ...
Cached Medicine Technology:Sinovac Announces Management Changes 2Sinovac Announces Management Changes 3Access Pharmaceuticals Retains Edelman as Public Relations Firm 2Access Pharmaceuticals Retains Edelman as Public Relations Firm 3
(Date:3/2/2015)... Over the last five years the ultrasound market has ... their geographic presence and achieve economies of scale. The ... by 2019 at CAGR of 5.1% from 2014 to ... and a major part of Europe are mature markets ... including China and India, Latin America and the Middle ...
(Date:3/2/2015)... LegitScript, LLC, operator of ... including those for Internet pharmacy certification, monitoring ... classification, has launched a certification program for ... program, called iCareRx , provides certification ... identity of the owner/operator of Internet websites, ...
(Date:3/2/2015)... WI (PRWEB) March 02, 2015 ... consultancy focused on quality, regulatory and technical consulting, ... as Chief Operating Officer. , Before joining ... experience leading R&D teams in all aspects of ... leadership positions at Covidien (Medtronic), Regulatory Compliance Associates ...
(Date:3/2/2015)... The Alliance for Bangladesh Worker Safety today announced ... serve as chief safety officer. In this role, he ... and guide remediation efforts in all factories from which ... the Alliance continues to bring world-class expertise to factory ... said Alliance Independent Chair Ellen Tauscher. “His role as ...
(Date:3/2/2015)... Aliso Viejo, California (PRWEB) March 02, 2015 ... the release of the TranStatic Volume 2 from Pixel Film ... glitch transitions made exclusively for FCPX,” said Christina Austin, CEO ... tool to have in any Final Cut Pro X editors ... one scene to the next with media altering static scrambling ...
Breaking Medicine News(10 mins):Health News:Therapeutic Ultrasound Devices Market worth $6.2 Billion by 2019 - New Research Report by MarketsandMarkets 2Health News:Therapeutic Ultrasound Devices Market worth $6.2 Billion by 2019 - New Research Report by MarketsandMarkets 3Health News:LegitScript Launches Certification Program for Internet Eyeglass Sellers 2Health News:Regulatory Compliance Associates® Inc. Welcomes Seyed Khorashahi as Chief Operating Officer 2Health News:Alliance for Bangladesh Worker Safety Names New Chief Safety Officer 2Health News:Pixel Film Studios released the TranStatic Volume 2 plugin for Final Cut Pro X today 2
... a new country is difficultlearning the cultural rules and meanings ... published in Psychological Science , a journal of the ... for children, but quickly becomes more difficult after about the ... many aspects of learning and development have a critical windowif ...
... is a great way to stay physically active while ... is that mountain biking-related injuries have decreased. A new ... Research and Policy of The Research Institute at Nationwide ... decreased 56 percent over the 14-year study period (1994 ...
... WEDNESDAY, Feb. 2 (HealthDay News) -- A large international trial finds ... as well as it protects young women. HPV is the ... linked to penile cancer and other malignancies in men. According ... New England Journal of Medicine , which was funded by the ...
... Phil predicted that spring will come on time, and NASA ... the U.S. are now anxious for the prediction to come ... over the last couple of days, including Phil,s home at ... and freezing rain this morning before it changed to snow ...
... Feb. 2 (HealthDay News) -- Researchers report that DNA analysis ... rare vascular disease, along with its genetic cause. As ... England Journal of Medicine , the debilitating, painful and progressive ... the hands and feet of patients, and in the vascular ...
... By Jenifer Goodwin HealthDay Reporter , ... autism have difficulty understanding others, intentions, new research shows. ... with autism, even those with high IQs, judge others ... maintaining relationships, the study found. Researchers from Massachusetts ...
Cached Medicine News:Health News:Younger immigrants adjust to a new culture faster than do older immigrants 2Health News:New national study finds mountain bike-related injuries down 56 percent 2Health News:Gardasil Vaccine Guards Against HPV in Boys 2Health News:GOES-13 Satellite sees Groundhog's Day on ice 2Health News:Scientists Discover Rare Vascular Disease 2Health News:Adults With Autism May Not Understand Others' Intentions 2Health News:Adults With Autism May Not Understand Others' Intentions 3
VG2 PLIF (Trapezoid) Posterior lumbar interbody fusion. Frozen preservation. Consists of two outer cortical planks, center cancellous plank, all from the same donor, held together by two press-fit co...
VG1 ALIF (Anterior) Anterior lumbar interbody fusion. Frozen freeze-dried preservation....
Allograft implants can be easily used to repair and promote the healing of a wide variety of bone and other tissue defects....
Solid cortical spacers with a natural anatomic fibular shape....
Medicine Products: